A trio large pharmas traded units amid continued emphasis on narrowly focused portfolios. Novartis bought a pair of GSK cancer drugs to complement its Gleevec franchise, and in turn sold its vaccines business to GSK while also selling its animal health division to Lilly.
Lessons from the Target hack for health IT. We heard some talk about privacy concerns at the ePharma Summit recently. Rough consensus seemed to be that if you're transparent and proactive in addressing privacy/security issues, and if patients can see a clear upside, they'll share their data.
EMS loyalty programs: pretty much a brilliant name for providing patient education and ongoing support to the small segment of patients that turn up in ERs like a bad penny.